Weekly Closed-End Fund Roundup (October 18, 2026)

CEFs fell this week: 7 of 26 sectors rose on price (average -0.88%) and 12 of 26 on NAV (average -0.30%); munis led while convertibles lagged. DMA announced a buyback and +2.2% distribution raise as it entered its term measurement period; ASGI's rights offering was about 34% subscribed at $19.28. At the fund level, NMS (+5.11%) led on price and KF fell the most (-15.39%); on NAV, BGR (+4.62%) led while KF dropped -16.09%.

Seeking Alpha • Oct 26, 2026

Weekly Closed-End Fund Roundup (October 11, 2026)

CEFs were mixed this week: 10 of 26 sectors rose on price (average -0.02%) and 15 of 26 on NAV (average +0.15%); MLPs led while Senior Loans lagged.

Seeking Alpha • Oct 18, 2026

BMEZ Tender Offer Quick Notes

BlackRock Health Sciences Term Trust will conduct a tender offer for up to 5% of its shares at 98% of NAV, expected to run from October 16 to November 18, 2026. The tender triggered automatically because BMEZ's average discount over the nine months ended September 30 was -11.05%, wider than the program's -10% threshold. At a -10.42% discount (October 12 close), tendering captures about 9.4% of alpha per accepted share, but only about 10% of tendered shares would be accepted at 50% participation.

Seeking Alpha • Oct 14, 2026

Weekly Closed-End Fund Roundup (October 4, 2026)

CEFs fell this week: 4 of 26 sectors rose on price (average -1.01%) and 1 of 26 on NAV (average -0.95%). IAE and IHD stop trading on October 13 and will reorganize at NAV into an open-end Voya fund. BMEZ's discount management program triggered a tender offer for 5% of its shares at 98% of NAV, expected to run from October 16 to November 18.

Seeking Alpha • Oct 12, 2026

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

Business Wire • Sep 30, 2026

BMEZ: Ride On Multiple Tailwinds Amid Sector Rotation

BlackRock Health Sciences Trust II offers a balanced biotech and pharma portfolio, with top holdings showing strong FCF margins and positive growth. BMEZ trades at a notable -10% NAV discount, presenting an attractive entry point as sector rotation into healthcare gains momentum. I expect healthcare to outperform through 2026, driven by lower valuations, technological innovation, and defensive positioning during midterm election cycles.

Seeking Alpha • Aug 4, 2026

BMEZ: Removal Of Options Should Improve Performance (Rating Upgrade)

BlackRock Health Sciences Trust II offers exposure to healthcare innovation but faces NAV instability and dividend sustainability concerns. BMEZ's strategy targets high-growth healthcare sectors, leveraging BlackRock's expertise, yet recent performance highlights volatility and risk to distributions. Potential growth in healthcare is supported by industry trends, but BMEZ's NAV fluctuations and payout risks warrant close monitoring.

Seeking Alpha • May 28, 2026

BMEZ: Sell, Distributions Down 34% And Undercovered

BlackRock Health Sciences Trust II yields 9.59% but has reduced its monthly payout by 34% to $0.11. BMEZ's NAV and net assets have declined sharply, with net assets dropping 44% over two years and persistent underperformance versus sector peers. Distributions are mostly return of capital (75%), offering tax deferral but eroding investor basis; distribution coverage remains weak at 0.38x.

Seeking Alpha • Mar 22, 2026

Forget Software Stocks: This 8.8% Dividend Is The Real AI Bargain

Wall Street is mired in another panic over AI. And we contrarians are here for it.

Forbes • Mar 4, 2026

BMEZ: Deep Discount Once Again Makes It An Interesting Play

BlackRock Health Sciences Term Trust (BMEZ) now trades at a compelling 12% discount, offering a potential entry for investors seeking relatively volatile healthcare exposure. BMEZ removed its options writing strategy, increasing reliance on capital appreciation from its biotech-tilted, growth-oriented portfolio for both returns and distribution coverage. The fund's distribution was cut from a 12% managed rate to a more sustainable payout level, with payouts primarily reliant on capital gains rather than income.

Seeking Alpha • Jan 4, 2026